Frontiers in medicine · 2026
Gelsolin amyloidosis presenting with nephrotic syndrome: a case report and molecular insights.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xiang Silin, Bi Peng, Chen Dazhou, Tang Wen, Li Yuan, Zhou Yali, Kang Dedong, Pan Chuqi, Wan Feng, Yu Jin, Tang Xuanli
Аннотация
Familial Amyloidosis of Finnish type (FAF) is a rare autosomal dominant hereditary amyloidosis associated with genetic variants of gelsolin. This condition is characterized by ophthalmologic abnormalities, progressive cranial neuropathy, and cutis laxa, while renal impairment is rare. We report a gelsolin amyloidosis in a 58-year-old man with nephrotic syndrome and slowly progressive kidney dysfunction, associated with a gelsolin gene mutation (c.480C > A, p.Asn160Lys). Initial renal biopsy showed segmental IgA deposition, moderate mesangial expansion with weak PAS positivity, and parallel bundles of 10 nm fibrils, but only trace Congo red staining. A second biopsy 2 years later revealed IgA-dominant deposition, nodular sclerosis, similar fibrils, glomerular basement membrane lamination, and weakly positive Congo red. The diagnosis of gelsolin amyloidosis was confirmed by mass spectrometry and immunohistochemistry. Clinically, the patient had no neuropathy or family renal disease but presented with gastrointestinal symptoms, and endoscopy confirmed vascular amyloid deposition. Molecular structure analysis suggested that the mutation may loosen the protein structure while preserving its calcium-binding ability. Combining with the literature, we discuss the clinicopathological features and predicted protein functions of mutated gelsolin, aiming to elucidate its pathogenic mechanisms and deepen the understanding of hereditary amyloidosis.